Cargando…
Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy: 20-year follow-up of the TIMIC trial( )
AIMS: Long-term results of the Tailored IMmunosuppression in virus-negative Inflammatory Cardiomyopathy (TIMIC) trial protocol have been evaluated. METHODS AND RESULTS: Eighty-five patients with endomyocardial biopsy-proven virus-negative chronic inflammatory cardiomyopathy were enrolled in the rand...
Autores principales: | Chimenti, Cristina, Russo, Matteo Antonio, Frustaci, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492235/ https://www.ncbi.nlm.nih.gov/pubmed/35831932 http://dx.doi.org/10.1093/eurheartj/ehac348 |
Ejemplares similares
-
Cardiomyopathies and Adrenal Diseases
por: Petramala, Luigi, et al.
Publicado: (2020) -
Pemphigus‐associated cardiomyopathy: report of autoimmune myocarditis and review of literature
por: Frustaci, Andrea, et al.
Publicado: (2021) -
Removal of cardiac AL amyloid with positive remodelling of cardiomyocytes and of restrictive cardiomyopathy
por: Frustaci, Andrea, et al.
Publicado: (2022) -
Hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease
por: Chimenti, Cristina, et al.
Publicado: (2021) -
Immune‐Mediated Myocarditis in Fabry Disease Cardiomyopathy
por: Frustaci, Andrea, et al.
Publicado: (2018)